Overexpression of FANCD2 is positively associated with tumor size and poor prognosis in breast cancer [8,9,10], ovarian cancer [11,12], nasopharyngeal carcinoma [13], glioblastoma [14], and endometrial carcinoma [15]. Here, FANCD2 is linked to breast carcinoma.